According to the news source, most of the job cuts are likely to involve sales personnel. The reduction also involves attrition and hiring freezes.
Loss of patent protection, lack of new medicines and increase in generic competition are reported to be some of the reasons behind the recent job cuts implemented by the global pharmaceutical companies.